Edit
Olema Pharmaceuticals
https://www.olemapharma.com/contactLast activity: 30.10.2025
Active - Reference to Olema Oncology
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
Employees: 1-10
Investors 2
| Date | Name | Website |
| - | Logos Capi... | logoscapit... |
| - | RA Capital... | racap.com |
Mentions in press and media 1
| Date | Title | Description |
| 30.10.2025 | Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here | Monday - Friday, 2:00 - 3:00 PM ET Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead c... |